Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,573 | -69,463 | -53,759 | -36,687 | -80,107 |
| Depreciation Amortization | 2,685 | 2,462 | 2,245 | 2,039 | 8,289 |
| Accounts receivable | -806 | N/A | N/A | N/A | 440 |
| Accounts payable and accrued liabilities | -866 | 2,072 | 3,736 | 1,112 | -5,607 |
| Other Working Capital | -25,970 | 5,394 | 7,143 | 2,455 | 25,769 |
| Other Operating Activity | 26,887 | 21,254 | 17,553 | 18,530 | 28,328 |
| Operating Cash Flow | $-52,643 | $-38,281 | $-23,082 | $-12,551 | $-22,888 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -382 | -346 | -285 | -41 | -41 |
| Investing Cash Flow | $-382 | $-346 | $-285 | $-41 | $-41 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 302 | N/A | N/A | N/A | 32,118 |
| Debt Repayment | -9 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 109,346 | 112,308 | 111,515 | 111,254 | 280 |
| Common Stock Repurchased | -10 | -10 | -10 | N/A | N/A |
| Other Financing Activity | -2,458 | -5,531 | -5,437 | -2,810 | 20,011 |
| Financing Cash Flow | $107,171 | $106,767 | $106,068 | $108,444 | $52,409 |
| Exchange Rate Effect | 3 | -11 | 5 | -3 | -444 |
| Beginning Cash Position | 34,607 | 34,607 | 34,607 | 34,607 | 5,571 |
| End Cash Position | 88,756 | 102,736 | 117,313 | 130,456 | 34,607 |
| Net Cash Flow | $54,149 | $68,129 | $82,706 | $95,849 | $29,036 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,643 | -38,281 | -23,082 | -12,551 | -22,888 |
| Capital Expenditure | -382 | -346 | -285 | -41 | -41 |
| Free Cash Flow | -53,025 | -38,627 | -23,367 | -12,592 | -22,929 |